APA (7th ed.) Citation

X, B., ZQ, G., YP, Z., ZZ, F., LJ, L., L, L., . . . ZY, D. (2023). CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nature communications, 14(1), 1247. https://doi.org/10.1038/s41467-023-36892-4

Chicago Style (17th ed.) Citation

X, Bai, et al. "CDK4/6 Inhibition Triggers ICAM1-driven Immune Response and Sensitizes LKB1 Mutant Lung Cancer to Immunotherapy." Nature Communications 14, no. 1 (2023): 1247. https://doi.org/10.1038/s41467-023-36892-4.

MLA (9th ed.) Citation

X, Bai, et al. "CDK4/6 Inhibition Triggers ICAM1-driven Immune Response and Sensitizes LKB1 Mutant Lung Cancer to Immunotherapy." Nature Communications, vol. 14, no. 1, 2023, p. 1247, https://doi.org/10.1038/s41467-023-36892-4.